MetaADEDB 2.0 @ LMMD
Minoxidil
(ZIMGGGWCDYVHOY-UHFFFAOYSA-N)
Structure
SMILES
Nc1cc(nc(=N)n1O)N1CCCCC1
Type(s)
Approved; Investigational
ATC code(s)
C02DC01; D11AX01
Molecular Formula:
C9H15N5O
Molecular Weight:
209.248
Log P:
0.9183
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
3
TPSA:
91.16
CAS Number(s):
38304-91-5
Synonym(s)
1.
Minoxidil
2.
Loniten
3.
Regaine
4.
Rogaine
5.
U 10858
External Link(s)
MeSHD008914
PubChem Compound4201
BindingDB50237593
81463
ChEBI6942
92128
CHEMBLCHEMBL802
CHEMBL1372483
CHEMBL609587
DrugBankDB00350
DrugCentral1814
IUPHAR/BPS Guide to PHARMACOLOGY4254
KEGGdr:D00418
Therapeutic Target DatabaseD0Y2CJ
ZINC1735
6507066
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 450OFFSIDES
US FAERS
2AlopeciaFAERS: 350
Canada Vigilance: 1

View details

CTD
OFFSIDES
Canada Vigilance
US FAERS
3Application site pruritusFAERS: 214OFFSIDES
US FAERS
4Inappropriate schedule of drug administrationFAERS: 170US FAERS
5PruritusFAERS: 156
Canada Vigilance: 1
2375560CTD
Canada Vigilance
US FAERS
6Drug administered at inappropriate siteFAERS: 143US FAERS
7DizzinessFAERS: 120
Canada Vigilance: 1
18789307CTD
OFFSIDES
Canada Vigilance
US FAERS
8Application site painFAERS: 111OFFSIDES
US FAERS
9Product use in unapproved indicationFAERS: 104US FAERS
10Product use issueFAERS: 102US FAERS
11Expired product administeredFAERS: 100US FAERS
12No adverse eventFAERS: 99US FAERS
13Wrong technique in product usage processFAERS: 92US FAERS
14Product administered at inappropriate siteFAERS: 88US FAERS
15HeadacheFAERS: 876156347CTD
US FAERS
16Application site erythemaFAERS: 81OFFSIDES
US FAERS
17Application site irritationFAERS: 81OFFSIDES
US FAERS
18Therapeutic response unexpectedFAERS: 76OFFSIDES
US FAERS
19HypersensitivityFAERS: 70
Canada Vigilance: 2
Canada Vigilance
US FAERS
20Incorrect dose administeredFAERS: 67OFFSIDES
US FAERS
21PalpitationsFAERS: 61US FAERS
22ErythemaFAERS: 57
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
23Dry skinFAERS: 53OFFSIDES
US FAERS
24Application site drynessFAERS: 52OFFSIDES
US FAERS
25Inappropriate schedule of product administrationFAERS: 50US FAERS
26Drug effect incompleteFAERS: 49US FAERS
27Application site exfoliationFAERS: 48OFFSIDES
US FAERS
28HypertrichosisFAERS: 48

View details

CTD
OFFSIDES
SIDER
US FAERS
29Accidental exposure to productFAERS: 47US FAERS
30Application site rashFAERS: 45OFFSIDES
US FAERS
31Skin irritationFAERS: 41US FAERS
32Chest PainFAERS: 40
Canada Vigilance: 2
6810208CTD
OFFSIDES
Canada Vigilance
US FAERS
33HypotensionFAERS: 40

View details

CTD
SIDER
US FAERS
34Pericardial effusionFAERS: 38

View details

CTD
OFFSIDES
SIDER
US FAERS
35TachycardiaFAERS: 38
Canada Vigilance: 1

View details

CTD
SIDER
Canada Vigilance
US FAERS
36Wrong drug administeredFAERS: 37OFFSIDES
US FAERS
37Erectile dysfunctionFAERS: 331905361
8303971
CTD
US FAERS
38Application site scabFAERS: 32OFFSIDES
US FAERS
39Drug ineffective for unapproved indicationFAERS: 32US FAERS
40NauseaFAERS: 31SIDER
US FAERS
41OverdoseFAERS: 31US FAERS
42Burning sensationFAERS: 30OFFSIDES
US FAERS
43PainFAERS: 302256586
2375560
CTD
OFFSIDES
US FAERS
44Chest discomfortFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
45Application site vesiclesFAERS: 27OFFSIDES
US FAERS
46Adverse eventFAERS: 24US FAERS
47Application site burnFAERS: 23OFFSIDES
US FAERS
48Intentional product misuseFAERS: 23US FAERS
49Product formulation issueFAERS: 23US FAERS
50Product quality issueFAERS: 23US FAERS
51VomitingFAERS: 23SIDER
US FAERS
52FatigueFAERS: 222256586
2375560
CTD
OFFSIDES
US FAERS
53AstheniaFAERS: 21OFFSIDES
US FAERS
54MalaiseFAERS: 21US FAERS
55SwellingFAERS: 21US FAERS
56PsoriasisFAERS: 20US FAERS
57Accidental exposureFAERS: 17US FAERS
58Toxicity to various agentsFAERS: 17US FAERS
59Application site papulesFAERS: 16US FAERS
60Application site reactionFAERS: 16
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
61Feeling abnormalFAERS: 16US FAERS
62Incorrect drug administration durationFAERS: 16US FAERS
63Myocardial InfarctionFAERS: 1611041102CTD
US FAERS
64Pain of skinFAERS: 16OFFSIDES
US FAERS
65Peripheral swellingFAERS: 16US FAERS
66UrticariaFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
67FlushingFAERS: 15US FAERS
68SyncopeFAERS: 15US FAERS
69AcneFAERS: 14OFFSIDES
US FAERS
70AnxietyFAERS: 14OFFSIDES
US FAERS
71DermatitisFAERS: 14SIDER
US FAERS
72Joint swellingFAERS: 14US FAERS
73ScabFAERS: 14OFFSIDES
US FAERS
74TinnitusFAERS: 13OFFSIDES
US FAERS
75Angina PectorisFAERS: 12
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
76Application site ulcerFAERS: 12US FAERS
77Cerebrovascular accidentFAERS: 12US FAERS
78TrichorrhexisFAERS: 12US FAERS
79VertigoFAERS: 12US FAERS
80Auricular swellingFAERS: 11OFFSIDES
US FAERS
81Eye irritationFAERS: 11US FAERS
82Product counterfeitFAERS: 11OFFSIDES
US FAERS
83Application site dischargeFAERS: 10OFFSIDES
US FAERS
84Atrial FibrillationFAERS: 10US FAERS
85Drug administered to patient of inappropriate ageFAERS: 10US FAERS
86EczemaFAERS: 10OFFSIDES
US FAERS
87Incorrect route of drug administrationFAERS: 10US FAERS
88Intentional drug misuseFAERS: 9US FAERS
89Skin WrinklingFAERS: 9OFFSIDES
US FAERS
90Visual ImpairmentFAERS: 9US FAERS
91Contraindicated product administeredFAERS: 8US FAERS
92Impaired work abilityFAERS: 8OFFSIDES
US FAERS
93Thermal burnFAERS: 8US FAERS
94Wrong patient received medicationFAERS: 8US FAERS
95CardiomegalyFAERS: 76085384
8169836
8238566
CTD
US FAERS
96ChillsFAERS: 7US FAERS
97Dark circles under eyesFAERS: 7US FAERS
98Electrocardiogram abnormalFAERS: 7SIDER
US FAERS
99GlaucomaFAERS: 7OFFSIDES
US FAERS
100Intentional product use issueFAERS: 7US FAERS
101Rash erythematousFAERS: 7US FAERS
102Respiratory distressFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
103Skin lesionFAERS: 7OFFSIDES
US FAERS
104Therapeutic product effect incompleteFAERS: 7US FAERS
105TremorFAERS: 7US FAERS
106Accidental drug intake by childFAERS: 6US FAERS
107Alanine Aminotransferase IncreasedFAERS: 6US FAERS
108Application site swellingFAERS: 6OFFSIDES
US FAERS
109DiscomfortFAERS: 6US FAERS
110EpistaxisFAERS: 6OFFSIDES
US FAERS
111FolliculitisFAERS: 6US FAERS
112InfectionFAERS: 6US FAERS
113LymphomaFAERS: 6OFFSIDES
US FAERS
114Medication ErrorFAERS: 6US FAERS
115Medication residue presentFAERS: 6US FAERS
116Sinus TachycardiaFAERS: 6US FAERS
117Skin reactionFAERS: 6US FAERS
118Skin test positiveFAERS: 6OFFSIDES
US FAERS
119Application site erosionFAERS: 5US FAERS
120Application site inflammationFAERS: 5OFFSIDES
US FAERS
121Aspartate Aminotransferase IncreasedFAERS: 5US FAERS
122AsthmaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
123Drug administration errorFAERS: 5US FAERS
124Drug prescribing errorFAERS: 5US FAERS
125Fluid overloadFAERS: 5OFFSIDES
US FAERS
126LymphadenopathyFAERS: 5US FAERS
127Product storage errorFAERS: 5US FAERS
128AgitationFAERS: 4US FAERS
129Application site hypersensitivityFAERS: 4US FAERS
130ArthralgiaFAERS: 4US FAERS
131Cardiac TamponadeFAERS: 44090485CTD
SIDER
US FAERS
132Caustic injuryFAERS: 4OFFSIDES
US FAERS
133DeafnessFAERS: 4OFFSIDES
US FAERS
134Disease recurrenceFAERS: 4OFFSIDES
US FAERS
135Drug dose omissionFAERS: 4US FAERS
136Drug effect delayedFAERS: 4US FAERS
137DysgeusiaFAERS: 4US FAERS
138DyspepsiaFAERS: 4US FAERS
139Facial paralysisFAERS: 4US FAERS
140LethargyFAERS: 4US FAERS
141Oropharyngeal painFAERS: 4US FAERS
142PallorFAERS: 4OFFSIDES
US FAERS
143PneumoniaFAERS: 4US FAERS
144Product label issueFAERS: 4US FAERS
145SomnolenceFAERS: 4US FAERS
146Therapeutic product effect decreasedFAERS: 4US FAERS
147Therapy non-responderFAERS: 4OFFSIDES
US FAERS
148ThrombocytopeniaFAERS: 4SIDER
US FAERS
149Wrong technique in drug usage processFAERS: 4US FAERS
150Abdominal PainFAERS: 3OFFSIDES
US FAERS
151Alcohol withdrawal syndromeFAERS: 3US FAERS
152AmnesiaFAERS: 3OFFSIDES
US FAERS
153AngioedemaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
154Application site acneFAERS: 3US FAERS
155Application site discomfortFAERS: 3US FAERS
156Application site infectionFAERS: 3US FAERS
157Application site warmthFAERS: 3US FAERS
158AscitesFAERS: 3US FAERS
159BlindnessFAERS: 3US FAERS
160Blood glucose increasedFAERS: 3US FAERS
161BronchitisFAERS: 3OFFSIDES
US FAERS
162CataractFAERS: 3US FAERS
163Cerebellar infarctionFAERS: 3US FAERS
164Cerebral InfarctionFAERS: 3US FAERS
165Complications of maternal exposure to therapeutic drugsFAERS: 3OFFSIDES
US FAERS
166DiplopiaFAERS: 3OFFSIDES
US FAERS
167Drug exposure during pregnancyFAERS: 3US FAERS
168Drug toxicityFAERS: 3OFFSIDES
US FAERS
169Expired drug administeredFAERS: 3OFFSIDES
US FAERS
170Extraocular Muscle ParesisFAERS: 3US FAERS
171Eye BurnsFAERS: 3OFFSIDES
US FAERS
172Eye painFAERS: 3US FAERS
173Gamma-Glutamyltransferase IncreasedFAERS: 3US FAERS
174GastritisFAERS: 3US FAERS
175General physical health deteriorationFAERS: 3OFFSIDES
US FAERS
176Hair injuryFAERS: 3US FAERS
177HemiparesisFAERS: 3OFFSIDES
US FAERS
178Hepatic InfectionFAERS: 3OFFSIDES
US FAERS
179HirsutismFAERS: 3877641
7302117
CTD
US FAERS
180Hypothalamo-pituitary disorderFAERS: 3US FAERS
181InflammationFAERS: 38658561CTD
US FAERS
182NervousnessFAERS: 3US FAERS
183Nonspecific reactionFAERS: 3US FAERS
184Penile size reducedFAERS: 3US FAERS
185PericarditisFAERS: 3

View details

CTD
OFFSIDES
SIDER
US FAERS
186Pharmaceutical product complaintFAERS: 3OFFSIDES
US FAERS
187PresyncopeFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
188Product administered to patient of inappropriate ageFAERS: 3US FAERS
189Product substitution issueFAERS: 3OFFSIDES
US FAERS
190Pulmonary HypertensionFAERS: 3OFFSIDES
US FAERS
191Pulmonary thrombosisFAERS: 3US FAERS
192Sexual DysfunctionFAERS: 3US FAERS
193Skin UlcerFAERS: 3US FAERS
194Thyroid NeoplasmFAERS: 3US FAERS
195VIIth nerve paralysisFAERS: 3US FAERS
196Ventricular hypertrophyFAERS: 3US FAERS
197Visual disturbanceFAERS: 3OFFSIDES
US FAERS
198Weight decreasedFAERS: 3US FAERS
199Abdominal discomfortFAERS: 2US FAERS
200Actinic keratosisFAERS: 2US FAERS
201Activities of daily living impairedFAERS: 2US FAERS
202Acute kidney injuryFAERS: 2387174CTD
US FAERS
203Acute myocardial infarctionFAERS: 2US FAERS
204Aphthous StomatitisFAERS: 2US FAERS
205Application site massFAERS: 2US FAERS
206Application site pustulesFAERS: 2OFFSIDES
US FAERS
207Application site urticariaFAERS: 2US FAERS
208Atrial FlutterFAERS: 2US FAERS
209Benign NeoplasmFAERS: 2US FAERS
210Blood creatinine increasedFAERS: 2OFFSIDES
SIDER
US FAERS
211Blood immunoglobulin E increasedFAERS: 2US FAERS
212Blood iron decreasedFAERS: 2US FAERS
213Blood pressure inadequately controlledFAERS: 2OFFSIDES
US FAERS
214Blood testosterone increasedFAERS: 2US FAERS
215BradycardiaFAERS: 2OFFSIDES
US FAERS
216Cardiac FlutterFAERS: 2US FAERS
217Cardiac enzymes increasedFAERS: 2US FAERS
218Cerebral ventricle dilatationFAERS: 2OFFSIDES
US FAERS
219Chemical burn of skinFAERS: 2US FAERS
220ChromaturiaFAERS: 2OFFSIDES
US FAERS
221Congenital hypertrichosisFAERS: 2OFFSIDES
US FAERS
222ConjunctivitisFAERS: 2US FAERS
223CystFAERS: 2US FAERS
224DisorientationFAERS: 2US FAERS
225Drug dispensing errorFAERS: 2US FAERS
226DysuriaFAERS: 2OFFSIDES
US FAERS
227Electrocardiogram changeFAERS: 2US FAERS
228ErythromelalgiaFAERS: 2OFFSIDES
US FAERS
229Exfoliative rashFAERS: 2OFFSIDES
US FAERS
230Eye InfectionFAERS: 2US FAERS
231FormicationFAERS: 2US FAERS
232Gastrointestinal motility disorderFAERS: 2US FAERS
233GoutFAERS: 2US FAERS
234Head deformityFAERS: 2OFFSIDES
US FAERS
235HypothyroidismFAERS: 2US FAERS
236HysterectomyFAERS: 2OFFSIDES
US FAERS
237Incorrect product administration durationFAERS: 2US FAERS
238InfertilityFAERS: 2US FAERS
239Intervertebral disc disorderFAERS: 2OFFSIDES
US FAERS
240Jugular vein distensionFAERS: 2US FAERS
241LeukocytosisFAERS: 2US FAERS
242LeukopeniaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
243Lip swellingFAERS: 2US FAERS
244Lymphocytic infiltrationFAERS: 2US FAERS
245MYELODYSPLASTIC SYNDROMEFAERS: 2US FAERS
246Medication residueFAERS: 2US FAERS
247Medication tamperingFAERS: 2OFFSIDES
US FAERS
248MenorrhagiaFAERS: 2US FAERS
249Molluscum ContagiosumFAERS: 2OFFSIDES
US FAERS
250Multiple SclerosisFAERS: 2US FAERS
251NasopharyngitisFAERS: 2OFFSIDES
US FAERS
252Night sweatsFAERS: 2US FAERS
253OliguriaFAERS: 2US FAERS
254OnychoclasisFAERS: 2US FAERS
255Oropharyngeal swellingFAERS: 2US FAERS
256PapuleFAERS: 2US FAERS
257PharyngitisFAERS: 2US FAERS
258Poor quality product administeredFAERS: 2US FAERS
259Prescription drug used without a prescriptionFAERS: 2US FAERS
260Product contaminationFAERS: 2US FAERS
261Product packaging issueFAERS: 2US FAERS
262Product residue presentFAERS: 2US FAERS
263Product tamperingFAERS: 2OFFSIDES
US FAERS
264Psychotic symptomFAERS: 2US FAERS
265Pulmonary EmbolismFAERS: 2US FAERS
266PurpuraFAERS: 2US FAERS
267Purulent dischargeFAERS: 2US FAERS
268Respiratory arrestFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
269RetchingFAERS: 2US FAERS
270Secretion dischargeFAERS: 2OFFSIDES
US FAERS
271Skin PapillomaFAERS: 2US FAERS
272Skin hypertrophyFAERS: 2OFFSIDES
US FAERS
273Skin tightnessFAERS: 2US FAERS
274Stevens-Johnson SyndromeFAERS: 2SIDER
US FAERS
275Suicide attemptFAERS: 2US FAERS
276Temporal ArteritisFAERS: 2US FAERS
277Throat irritationFAERS: 2US FAERS
278TrichotillomaniaFAERS: 2US FAERS
279UlcerFAERS: 2OFFSIDES
US FAERS
280Unevaluable eventFAERS: 2US FAERS
281Vascular anomalyFAERS: 2OFFSIDES
US FAERS
282AbasiaFAERS: 1OFFSIDES
US FAERS
283Abnormal weight gainFAERS: 1US FAERS
284Accidental exposure to product by childFAERS: 1US FAERS
285Accidental overdoseFAERS: 1US FAERS
286AkathisiaFAERS: 1US FAERS
287Allergy test positiveFAERS: 1US FAERS
288Allergy to chemicalsFAERS: 1US FAERS
289AlveolitisFAERS: 1OFFSIDES
US FAERS
290AmblyopiaFAERS: 1OFFSIDES
US FAERS
291Ammonia increasedFAERS: 1US FAERS
292Anal FistulaFAERS: 1OFFSIDES
US FAERS
293Anaphylactic shockFAERS: 1US FAERS
294AneurysmFAERS: 1US FAERS
295Angiogram abnormalFAERS: 1US FAERS
296AnorexiaFAERS: 12375560CTD
OFFSIDES
US FAERS
297AppendicitisFAERS: 1US FAERS
298Application site eczemaFAERS: 1OFFSIDES
US FAERS
299Application site folliculitisFAERS: 1US FAERS
300Application site lacerationFAERS: 1US FAERS
301ArteriosclerosisFAERS: 1OFFSIDES
US FAERS
302Arteriovenous fistulaFAERS: 1OFFSIDES
US FAERS
303AsphyxiaFAERS: 1US FAERS
304Atrioventricular BlockFAERS: 1OFFSIDES
US FAERS
305Basal cell carcinomaFAERS: 1US FAERS
306BedriddenFAERS: 1US FAERS
307Bladder discomfortFAERS: 1US FAERS
308Blood count abnormalFAERS: 1US FAERS
309Blood iron abnormalFAERS: 1US FAERS
310Blood prolactin increasedFAERS: 1US FAERS
311Blood testosterone decreasedFAERS: 1US FAERS
312Blood urea increasedFAERS: 1US FAERS
313Bone marrow depressionFAERS: 1OFFSIDES
US FAERS
314Bone painFAERS: 1OFFSIDES
US FAERS
315BronchiolitisFAERS: 1US FAERS
316BronchopneumoniaFAERS: 1US FAERS
317Cardiac HypertrophyFAERS: 1OFFSIDES
US FAERS
318Cerebral atrophyFAERS: 1OFFSIDES
US FAERS
319Cervix carcinoma recurrentFAERS: 1US FAERS
320Cervix carcinomaFAERS: 1US FAERS
321Chemical burns of eyeFAERS: 1US FAERS
322Chemical injuryFAERS: 1US FAERS
323ChemotherapyFAERS: 1US FAERS
324ChokingFAERS: 1US FAERS
325ChromatopsiaFAERS: 1US FAERS
326ClaustrophobiaFAERS: 1US FAERS
327Cold sweatFAERS: 1US FAERS
328Congenital cerebellar agenesisFAERS: 1US FAERS
329ConstipationFAERS: 1US FAERS
330Contraindicated drug administeredFAERS: 1US FAERS
331Contraindicated drug prescribedFAERS: 1US FAERS
332CryingFAERS: 1US FAERS
333Dacryostenosis acquiredFAERS: 1US FAERS
334DeformityFAERS: 1US FAERS
335DehydrationFAERS: 1US FAERS
336DemyelinationFAERS: 1US FAERS
337Depressed moodFAERS: 1US FAERS
338Device FailureFAERS: 1US FAERS
339Diabetes InsipidusFAERS: 1US FAERS
340Diabetes MellitusFAERS: 1US FAERS
341Disseminated Intravascular CoagulationFAERS: 1OFFSIDES
US FAERS
342Drug DependenceFAERS: 1US FAERS
343Drug administered in wrong deviceFAERS: 1US FAERS
344Drug effect variableFAERS: 1US FAERS
345Ear discomfortFAERS: 1US FAERS
346Eczema impetiginousFAERS: 1US FAERS
347Eczema weepingFAERS: 1US FAERS
348Electrocardiogram ST-T changeFAERS: 1US FAERS
349Emotional distressFAERS: 1US FAERS
350EpididymitisFAERS: 1US FAERS
351EpilepsyFAERS: 1US FAERS
352Erection increasedFAERS: 1US FAERS
353Erythema MultiformeFAERS: 1SIDER
US FAERS
354Escherichia urinary tract infectionFAERS: 1US FAERS
355ExcoriationFAERS: 1US FAERS
356Exposure via inhalationFAERS: 1US FAERS
357Eye inflammationFAERS: 1US FAERS
358Eyelid irritationFAERS: 1US FAERS
359Feeling of body temperature changeFAERS: 1US FAERS
360FlatulenceFAERS: 1US FAERS
361Genital dischargeFAERS: 1US FAERS
362GranulocytosisFAERS: 1US FAERS
363Head discomfortFAERS: 1US FAERS
364Heart sounds abnormalFAERS: 1US FAERS
365Hepatic necrosisFAERS: 1US FAERS
366HepatitisFAERS: 1OFFSIDES
US FAERS
367HerniaFAERS: 1OFFSIDES
US FAERS
368HoarsenessFAERS: 1US FAERS
369HungerFAERS: 1US FAERS
370HyperacusisFAERS: 1US FAERS
371HyperkeratosisFAERS: 1US FAERS
372HyperventilationFAERS: 1US FAERS
373Hypoaesthesia facialFAERS: 1US FAERS
374HypotrichosisFAERS: 1US FAERS
375HypoxiaFAERS: 1US FAERS
376ImpetigoFAERS: 1US FAERS
377Incorrect product storageFAERS: 1US FAERS
378Inflammatory painFAERS: 1US FAERS
379InfluenzaFAERS: 1US FAERS
380Initial insomniaFAERS: 1US FAERS
381Injection site pruritusFAERS: 1US FAERS
382Insulin-requiring type 2 diabetes mellitusFAERS: 1US FAERS
383Intentional self-injuryFAERS: 1US FAERS
384Intercepted drug administration errorFAERS: 1US FAERS
385KeratitisFAERS: 1US FAERS
386LacerationFAERS: 1OFFSIDES
US FAERS
387LaryngitisFAERS: 1US FAERS
388LazinessFAERS: 1US FAERS
389LentigoFAERS: 1US FAERS
390LymphocytosisFAERS: 1OFFSIDES
US FAERS
391LymphopeniaFAERS: 1US FAERS
392Maternal exposure during pregnancyFAERS: 1US FAERS
393Memory impairmentFAERS: 1US FAERS
394Mental status changesFAERS: 1OFFSIDES
US FAERS
395MesotheliomaFAERS: 1US FAERS
396MetamorphopsiaFAERS: 1US FAERS
397Moyamoya DiseaseFAERS: 1US FAERS
398Musculoskeletal PainFAERS: 1US FAERS
399Musculoskeletal stiffnessFAERS: 1US FAERS
400MyalgiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
401MyocarditisFAERS: 1US FAERS
402Nasal discomfortFAERS: 1US FAERS
403Neck PainFAERS: 1US FAERS
404NeuralgiaFAERS: 1US FAERS
405ObesityFAERS: 1US FAERS
406Ocular discomfortFAERS: 1US FAERS
407Ocular vascular disorderFAERS: 1US FAERS
408Oculogyric crisisFAERS: 1US FAERS
409Optic NeuritisFAERS: 16342503CTD
OFFSIDES
US FAERS
410Oral mucosal erythemaFAERS: 1US FAERS
411Orchitis noninfectiveFAERS: 1US FAERS
412OsteomyelitisFAERS: 1US FAERS
413Pathologic myopiaFAERS: 1US FAERS
414Peritoneal DialysisFAERS: 1US FAERS
415PetechiaeFAERS: 1US FAERS
416Pharyngolaryngeal PainFAERS: 1OFFSIDES
US FAERS
417Physical product label issueFAERS: 1US FAERS
418Placental InsufficiencyFAERS: 1US FAERS
419PoisoningFAERS: 1US FAERS
420Post procedural complicationFAERS: 1US FAERS
421Premenstrual syndromeFAERS: 1US FAERS
422Procedural complicationFAERS: 1US FAERS
423Product contamination chemicalFAERS: 1US FAERS
424Product lot number issueFAERS: 1US FAERS
425Product packaging quantity issueFAERS: 1US FAERS
426Product physical consistency issueFAERS: 1US FAERS
427Product physical issueFAERS: 1US FAERS
428Product prescribing errorFAERS: 1US FAERS
429Product use complaintFAERS: 1US FAERS
430Product used for unknown indicationFAERS: 1US FAERS
431Pulmonary congestionFAERS: 1US FAERS
432PurulenceFAERS: 1US FAERS
433Pyoderma GangrenosumFAERS: 1US FAERS
434Quadruple vessel bypass graftFAERS: 1US FAERS
435Quality of life decreasedFAERS: 1US FAERS
436Reaction to medical agent preservativesFAERS: 1US FAERS
437Renal cystFAERS: 1US FAERS
438Renal tubular necrosisFAERS: 1US FAERS
439Respiratory DepressionFAERS: 1US FAERS
440Respiratory tract congestionFAERS: 1US FAERS
441RestlessnessFAERS: 1US FAERS
442RhabdomyolysisFAERS: 1US FAERS
443Right ventricular diastolic collapseFAERS: 1US FAERS
444Rotator cuff syndromeFAERS: 1US FAERS
445SciaticaFAERS: 1US FAERS
446ScotomaFAERS: 1US FAERS
447SepsisFAERS: 1US FAERS
448Sexual activity increasedFAERS: 1US FAERS
449Skin IndurationFAERS: 1US FAERS
450SneezingFAERS: 1US FAERS
451Squamous cell carcinomaFAERS: 1US FAERS
452StomatitisFAERS: 1US FAERS
453StressFAERS: 1OFFSIDES
US FAERS
454SunburnFAERS: 1US FAERS
455SuperinfectionFAERS: 1US FAERS
456Supraventricular tachycardiaFAERS: 1OFFSIDES
US FAERS
457Suspected product contaminationFAERS: 1US FAERS
458Swelling of eyelidFAERS: 1US FAERS
459Therapeutic response delayedFAERS: 1US FAERS
460Therapy regimen changedFAERS: 1US FAERS
461ThirstFAERS: 1US FAERS
462ThrombosisFAERS: 1US FAERS
463Toxic Epidermal NecrolysisFAERS: 1SIDER
US FAERS
464Toxic Shock SyndromeFAERS: 1US FAERS
465Trisomy 21FAERS: 1US FAERS
466Troponin I increasedFAERS: 1US FAERS
467Troponin increasedFAERS: 1US FAERS
468TuberculosisFAERS: 1US FAERS
469Ulnar Nerve PalsyFAERS: 1US FAERS
470Ultrasound scan abnormalFAERS: 1OFFSIDES
US FAERS
471Umbilical herniaFAERS: 1US FAERS
472Urinary RetentionFAERS: 1US FAERS
473Urinary tract infection staphylococcalFAERS: 1OFFSIDES
US FAERS
474Urinary tract infectionFAERS: 1US FAERS
475Vaginal burning sensationFAERS: 1US FAERS
476VasculitisFAERS: 1US FAERS
477Vasoplegia syndromeFAERS: 1US FAERS
478Violence-related symptomFAERS: 1US FAERS
479Vitamin B6 decreasedFAERS: 1US FAERS
480Vulvovaginal erythemaFAERS: 1US FAERS
481Vulvovaginal painFAERS: 1US FAERS
482Wrong technique in device usage processFAERS: 1US FAERS
483heart rateFAERS: 1US FAERS
484nervous system disorderFAERS: 1US FAERS
485treatment failureFAERS: 1US FAERS
486Abdominal AbscessOFFSIDES
487AcanthosisOFFSIDES
488Acid refluxOFFSIDES
489Acromegaly12789195CTD
490Acute respiratory failureOFFSIDES
491AdenocarcinomaOFFSIDES
492AdenomaOFFSIDES
493Adnexa uteri painOFFSIDES
494AdnexitisOFFSIDES
495Ageusia2375560CTD
OFFSIDES
496Alopecia Areata2408425
17191059
18789307
CTD
497Altered bowel functionOFFSIDES
498AngerOFFSIDES
499AngioplastyOFFSIDES
500AnhedoniaOFFSIDES
501AnosmiaOFFSIDES
502Anoxic EncephalopathyOFFSIDES
503Anticholinergic SyndromeOFFSIDES
504Aortic valve sclerosisOFFSIDES
505ApathyOFFSIDES
506Arteriovenous fistula site complicationOFFSIDES
507Arteriovenous fistula thrombosisOFFSIDES
508ArthritisOFFSIDES
509AtelectasisOFFSIDES
510AuraOFFSIDES
511Autoimmune thrombocytopeniaOFFSIDES
512Blood alkaline phosphatase increasedSIDER
513Blood and lymphatic system disordersSIDER
514Blood creatine abnormalOFFSIDES
515Blood erythropoietin increasedOFFSIDES
516Blood glucose decreasedOFFSIDES
517Blood glucose fluctuationOFFSIDES
518Blood pressure fluctuationOFFSIDES
519Blood sodiumOFFSIDES
520Blurred visionOFFSIDES
521Body TemperatureOFFSIDES
522Brain natriuretic peptide increasedOFFSIDES
523Breast discomfortOFFSIDES
524Breast tendernessSIDER
525Bullous eruptionSIDER
526Cardiac valve vegetationOFFSIDES
527Cardiomyopathies

View details

CTD
528Cardiovascular Diseases8658561
17191059
18582543
CTD
529Catheter placementOFFSIDES
530Caudal Regression SyndromeOFFSIDES
531CausalgiaOFFSIDES
532CellulitisOFFSIDES
533Cervical laser therapyOFFSIDES
534CheilitisOFFSIDES
535Choking sensationOFFSIDES
536CholecystitisOFFSIDES
537Chronic Obstructive Airway DiseaseOFFSIDES
538Chronic ulcerative colitisOFFSIDES
539ColitisOFFSIDES
540ConfabulationOFFSIDES
541Congenital tricuspid valve incompetenceOFFSIDES
542Conjunctival depositOFFSIDES
543Conjunctival irritationOFFSIDES
544Contact DermatitisOFFSIDES
545Dental cariesOFFSIDES
546Device interactionOFFSIDES
547Device related infectionOFFSIDES
548Diabetic RetinopathyOFFSIDES
549Disturbance in sexual arousalOFFSIDES
550DiverticulitisOFFSIDES
551DiverticulumOFFSIDES
552Drug addictOFFSIDES
553Drug withdrawal headacheOFFSIDES
554Dry gangreneOFFSIDES
555Duodenal UlcerOFFSIDES
556DuodenitisOFFSIDES
557Dyspnoea exacerbatedOFFSIDES
558Edema776581CTD
559Embolic strokeOFFSIDES
560EndocarditisOFFSIDES
561Endometrial hypertrophyOFFSIDES
562Endotracheal intubation complicationOFFSIDES
563Enterococcal infectionOFFSIDES
564Facial wastingOFFSIDES
565Factor V Leiden mutationOFFSIDES
566Fever2375560CTD
567Flank PainOFFSIDES
568Gastric mucosal lesionOFFSIDES
569GastroenteritisOFFSIDES
570Genital discomfortOFFSIDES
571GiardiasisOFFSIDES
572GliosisOFFSIDES
573GoiterOFFSIDES
574Hearing Loss, Bilateral3390339CTD
575Heart Diseases2047568CTD
576Heart failure7137047
9923399
CTD
577Hemorrhage

View details

CTD
578Hepatitis B positiveOFFSIDES
579HepatotoxicityOFFSIDES
580HyperpigmentationOFFSIDES
581Hypertensive emergencyOFFSIDES
582Hypotension, Orthostatic790007CTD
583Impaired gastric emptyingOFFSIDES
584Intervertebral Disc DegenerationOFFSIDES
585IridocyclitisOFFSIDES
586Ischemia15167272CTD
587Kidney FailureOFFSIDES
588Lactose IntoleranceOFFSIDES
589Low turnover osteopathyOFFSIDES
590Lung consolidationOFFSIDES
591Lung hyperinflationOFFSIDES
592Lupus NephritisOFFSIDES
593Malignant HypertensionOFFSIDES
594Malignant renal hypertensionOFFSIDES
595MalnutritionSIDER
596MastoiditisOFFSIDES
597Mediastinal FibrosisOFFSIDES
598Mental impairmentOFFSIDES
599Multi-organ disorderOFFSIDES
600Muscle FatigueOFFSIDES
601Mycosis FungoidesOFFSIDES
602Myoclonic EpilepsyOFFSIDES
603MyopericarditisOFFSIDES
604Necrosis

View details

CTD
605Nephrogenic Fibrosing DermopathyOFFSIDES
606NephrolithiasisOFFSIDES
607NeurodermatitisOFFSIDES
608Nicotine DependenceOFFSIDES
609Nodule on extremityOFFSIDES
610OligomenorrheaOFFSIDES
611OrthopneaOFFSIDES
612Otitis Externa3390339CTD
613ParanoiaOFFSIDES
614Parvovirus B19 serology positiveOFFSIDES
615Polymyalgia Rheumatica2256586
2375560
CTD
616Post procedural dizzinessOFFSIDES
617Post-traumatic painOFFSIDES
618ProctitisOFFSIDES
619Productive CoughOFFSIDES
620Proteinuria16645303CTD
621Prothrombin time ratio increasedOFFSIDES
622Radiation PneumonitisOFFSIDES
623Reflex Sympathetic DystrophyOFFSIDES
624Renal Artery StenosisOFFSIDES
625Renal Insufficiency6156352
16645303
CTD
626Respiratory FailureOFFSIDES
627Retinal Vein OcclusionOFFSIDES
628Retinal infarctionOFFSIDES
629Retinitis6342503CTD
630RhinorrheaOFFSIDES
631SalpingitisOFFSIDES
632Semen analysis abnormalCanada Vigilance: 1Canada Vigilance
633Sinus bradycardiaOFFSIDES
634SinusitisOFFSIDES
635Submandibular massOFFSIDES
636Temperature intoleranceOFFSIDES
637Testis discomfortOFFSIDES
638ThrombectomyOFFSIDES
639Thrombosis in deviceOFFSIDES
640Unresponsive to stimuliOFFSIDES
641Urethral dischargeOFFSIDES
642Urinary tract infection pseudomonalOFFSIDES
643Vascular Access ComplicationOFFSIDES
644Vascular calcificationOFFSIDES
645Vena cava filter insertionOFFSIDES
646Venous occlusionOFFSIDES
647Vitreous DetachmentOFFSIDES
648Vulvovaginal discomfortOFFSIDES
649Weight GainOFFSIDES
650Wound InfectionOFFSIDES
651colonoscopyOFFSIDES
652leiomyosarcomaOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.